enGene Therapeutics Inc. (ENGN)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
1.5300 - Open
1.5500 - Bid 1.1100 x 200
- Ask 1.8600 x 200
- Day's Range
1.4500 - 1.5500 - 52 Week Range
1.4000 - 12.2500 - Volume
587,041 - Avg. Volume
757,717 - Market Cap (intraday)
97.174M - Beta (5Y Monthly) -0.24
- PE Ratio (TTM)
-- - EPS (TTM)
-2.0700 - Earnings Date (est.) Dec 22, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
3.29 - Zacks Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-32.00%
-
Return on Equity (ttm)
-60.50%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-130.36M
-
Diluted EPS (ttm)
-2.0700
Balance Sheet and Cash Flow
-
Total Cash (mrq)
266.32M
-
Total Debt/Equity (mrq)
14.45%
-
Levered Free Cash Flow (ttm)
-60.85M
